Evaluation reports

SRC - Signalisation, radiobiologie et cancer

Type: Research entity evaluation report
Evaluation campaign: 2018-2019 (group E) - Published on: 14/06/2019
Institution(s) concerned: Institut Curie , Centre national de la recherche scientifique - CNRS , Institut national de la santé et de la recherche médicale - INSERM , Université Paris-Sud
Disciplinary research field: Life and Earth Sciences (SVE); SVE2 Cellular Biology, Imaging, Molecular Biology, Biochemistry, Genomics, Systemic Biology, Development, Structural Biology; SVE5 Physiology, Physiopathology, Cardiology, Pharmacology, Enocrinology, Cancer, Medical Technologies
Scientific field(s): 5 - Biologie, medecine et santé
ERC panel(s): LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome; LS3 Cellular and Developmental Biology: cell biology, cell physiology, signal transduction, organogenesis, developmental genetics, pattern formation in plants and animals; LS1 Molecular and Structural Biology and Biochemistry: molecular biology, biochemistry, biophysics, structural biology, biochemistry of signal transduction
Name of unit teams: Signaling and neural crest developement; Normal an pathological development of melanocytes; Signaling and Cancer Progression; Signaling in development and brain tumors; Tumor Microenvironnement; DNA Repair, radiations and innovative cancer therapies; TGF-B and oncogenesis
Keywords: Melanoma; medulloplastoma; cell biology; signal transduction; developmental genetics; tumorigenesis

Download file